Yesterday
Oaktree Capital kicks off debt process for GenesisCare
It is understood McKnight will seek to refinance the so-called “take-back debt”, a facility that was arranged and funded by the Oaktree-led consortium of financiers.
Healthscope asks to hand over Sydney hospital as it kicks off auction
The Brookfield-owned company is the country’s second-largest private hospital operator and says it cannot run the Northern Beaches Hospital any longer.
Should private equity firms own hospitals?
This week on The Fin podcast, Michael Smith on the Healthscope takeover battle, the war between insurers and hospitals and whether private equity firms are the right owners.
This Month
Pharmaceuticals to be hit by ‘major’ Trump tariff, CSL slumps 5pc
Investors are in panic as Australian drug companies could be the next victims in an expansion of the US trade war.
TPG buys majority stake in home care biz Five Good Friends
TPG’s Joel Thickins said Five Good Friends’ mission closely aligned with the firm’s focus on backing tech-enabled businesses with the ability to improve healthcare outcomes.
PEP bows out at Advent’s Imaging Associates
The radiology sector has offered up rich pickings for buyout firms in recent years.
Tensions build between David Di Pilla’s HMC Capital and Healthscope
When the hospitals group ran out of money to pay its rent this year, its landlord responded with a bid to buy the company.
Cheaper weight loss drugs would boost economy: study
The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?
Teal corflute bandit could have been a medtech star
Peter Jordan’s timing at leaving dud businesses is better than his ability to get away from scenes of election poster shenanigans.
Di Pilla spruiks Healthscope bid, says he’ll keep hospitals running
The veteran dealmaker’s HMC Capital has been eyeing the country’s second-largest operator of private hospitals, and says his proposal is “a serious one”.
March
Hedge fund interest in Healthscope triggers break-up concerns
The country’s second-largest private hospital operator is negotiating with lenders to stave off insolvency in the middle of a federal election campaign.
The battle to save Healthscope is about more than money
The fight over the hospital giant will pit heavyweight deal makers against each other. And questions of politics and social licence will make it complicated.
TPG Capital seals $3b-plus Novotech sale with Singapore’s GIC, Temasek
The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity giant for eight years.
HCF chief Sheena Jack resigns with a warning about healthcare’s future
The head of one of the country’s biggest health insurers says she’s not convinced private equity should be allowed to invest in hospitals.
The clinical trial result from hell has biotech investors on edge
From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea. Now they risk being wiped out.
How Ozempic and other GLP-1s are transforming much more than just waistlines
We don’t yet know how many Australians are taking the jab, but we’re certainly seeing the effects.
HCF CEO allegedly froze out leadership rival before sacking her
The health insurance giant’s former chief information officer says staff were told she was terminated despite a “vague” investigation yet to be finished.
Deleting genetic data held by failed firm might not stop it being sold
Cybersecurity experts say genetic testing company 23andMe could take a long time to permanently erase customers’ data once a request is made.
Tim Gurner’s health spa has the makings of a tax write-off
The property developer bans phones and laptops at his spa complex, which somehow also doubles as a co-working space.
Investors fret over clinical trial failure’s hit on Regal funds
Phil King’s investment firm was the largest shareholder in Opthea, the eye treatment play that could become insolvent after a poor medical result.
The healthcare policies rising at more than double the average
Many Australians and scaling down their private health insurance because of the cost, which is helping to drive premium increases to between 7 and 9 per cent.
Why some men find orgasms elusive
Reaching climax in 30 minutes or more can be uncomfortable, painful and distressing for males and their partners. Here are four causes and three remedies.
Why US drug giants are so angry about Australia’s PBS
US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays for their drugs.
Dutton promises to match Labor’s $25 prescription drugs pledge
The opposition has moved swiftly to match the government’s commitment to cut the cost of medicines by $6.60 per script.
Albanese pledges cheaper medicines with $25 scripts
Labor will pledge to cut subsidised prescription medicines by more than 25 per cent as it seeks to bolster its health credentials ahead of an election.